HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cross-linking of scleral collagen in the rabbit using riboflavin and UVA.

AbstractPURPOSE:
Scleral biomechanical weakness and thinning is known to be one of the main factors in the pathogenesis of progressive myopia. We tried to strengthen rabbit sclera by cross-linking scleral collagen using ultraviolet A (UVA) and the photosensitizer riboflavin.
METHODS:
Circumscribed 10 x10 mm sectors of the posterior--equatorial sclera of six chinchilla rabbit eyes were treated in vivo using a UVA double diode with 4.2 mW/cm(2) UVA at 370 nm and applying 0.1% riboflavin-5-phosphate drops as photosensitizer for 30 min. 1 day postoperatively biomechanical stress--strain measurements of three treated scleral strips were performed using a microcomputer-controlled biomaterial testing device and compared to non-treated contralateral control sclera. In addition, three treated eyes were examined histologically by light microscopy, TUNEL staining and electron microscopy to evaluate side-effects.
RESULTS:
Following the cross-linking treatment, the ultimate stress was 11.87+/-1.8 MPa versus 3.63+/-0.40 in the controls (increase of 227.9%, p=0.014), Young's modulus 27.67+/-4.16 MPa versus 4.9+/-.15 MPa in the controls (increase of 464.7%, p=0.021) and ultimate strain 92.2+/-7.43% versus 165.63+/-19.09% in the controls (decrease of 54.52%, p=0.012). Histologically, serious side-effects were found in the entire posterior globe with almost complete loss of the photoreceptors, the outer nuclear layer and the retinal pigment epithelium (RPE).
CONCLUSIONS:
Our new method of scleral collagen cross-linking proved very effective in increasing the scleral mechanical strength; the new treatment may represent an option for strengthening scleral tissue in progressive myopia. However, serious side-effects were observed in the outer retina. In future studies these side-effects could be avoided by reducing the irradiation dose below the cytotoxic level of the retina. Before its clinical application, the new method should be tested in a myopia animal model.
AuthorsGregor Wollensak, Elena Iomdina, Dag-Daniel Dittert, Olga Salamatina, Gisela Stoltenburg
JournalActa ophthalmologica Scandinavica (Acta Ophthalmol Scand) Vol. 83 Issue 4 Pg. 477-82 (Aug 2005) ISSN: 1395-3907 [Print] Denmark
PMID16029274 (Publication Type: Journal Article)
Chemical References
  • Cross-Linking Reagents
  • Photosensitizing Agents
  • Collagen
  • Riboflavin
Topics
  • Animals
  • Biomechanical Phenomena
  • Collagen (chemistry, metabolism, ultrastructure)
  • Cross-Linking Reagents
  • Female
  • In Situ Nick-End Labeling
  • Microscopy, Electron
  • Photoreceptor Cells, Vertebrate (drug effects, radiation effects, ultrastructure)
  • Photosensitizing Agents (pharmacology, toxicity)
  • Rabbits
  • Radiation Injuries, Experimental (pathology)
  • Retinal Diseases (pathology)
  • Riboflavin (pharmacology, toxicity)
  • Sclera (drug effects, radiation effects)
  • Ultraviolet Rays (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: